Clinical Trial Update: Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye. [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating the safety and effectiveness of ILUVIEN (190 μg) in children and adolescents with recurrent non-infectious uveitis affecting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posterior Uveitis
• Uveitis

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Non-infectious Uveitis Affecting the Posterior Segment of the Eye | Phase 4 | Status: RECRUITING